G-protein-coupled Receptor Kinase Specificity for β-Arrestin Recruitment to the β2-Adrenergic Receptor Revealed by Fluorescence Resonance Energy Transfer*

The small family of G-protein-coupled receptor kinases (GRKs) regulate cell signaling by phosphorylating heptahelical receptors, thereby promoting receptor interaction with β-arrestins. This switches a receptor from G-protein activation to G-protein desensitization, receptor internalization, and β-arrestin-dependent signal activation. However, the specificity of GRKs for recruiting β-arrestins to specific receptors has not been elucidated. Here we use the β2-adrenergic receptor (β2AR), the archetypal nonvisual heptahelical receptor, as a model to test functional GRK specificity. We monitor endogenous GRK activity with a fluorescence resonance energy transfer assay in live cells by measuring kinetics of the interaction between the β2AR and β-arrestins. We show that β2AR phosphorylation is required for high affinity β-arrestin binding, and we use small interfering RNA silencing to show that HEK-293 and U2-OS cells use different subsets of their expressed GRKs to promote β-arrestin recruitment, with significant GRK redundancy evident in both cell types. Surprisingly, the GRK specificity for β-arrestin recruitment does not correlate with that for bulk receptor phosphorylation, indicating that β-arrestin recruitment is specific for a subset of receptor phosphorylations on specific sites. Moreover, multiple members of the GRK family are able to phosphorylate the β2AR and induce β-arrestin recruitment, with their relative contributions largely determined by their relative expression levels. Because GRK isoforms vary in their regulation, this partially redundant system ensures β-arrestin recruitment while providing the opportunity for tissue-specific regulation of the rate of β-arrestin recruitment.

[1]  R. Mullins,et al.  β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.

[2]  J. Benovic,et al.  Differential Roles of Arrestin-2 Interaction with Clathrin and Adaptor Protein 2 in G Protein-coupled Receptor Trafficking* , 2002, The Journal of Biological Chemistry.

[3]  A. Burlingame,et al.  Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. , 2005, Biochemistry.

[4]  M. Caron,et al.  Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. , 1992, The Journal of biological chemistry.

[5]  R. Lefkowitz,et al.  Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  V. Gurevich,et al.  The molecular acrobatics of arrestin activation. , 2004, Trends in pharmacological sciences.

[7]  M. Caron,et al.  Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Martin J. Lohse,et al.  β-Arrestin Binding to the β2-Adrenergic Receptor Requires Both Receptor Phosphorylation and Receptor Activation* , 2005, Journal of Biological Chemistry.

[9]  R. Tsien,et al.  Creating new fluorescent probes for cell biology , 2002, Nature Reviews Molecular Cell Biology.

[10]  Malcolm W Johnson The β -Adrenoceptor , 1998 .

[11]  M. Caron,et al.  The mammalian beta 2-adrenergic receptor: purification and characterization. , 1984, Biochemistry.

[12]  M. Caron,et al.  Molecular Determinants Underlying the Formation of Stable Intracellular G Protein-coupled Receptor-β-Arrestin Complexes after Receptor Endocytosis* , 2001, The Journal of Biological Chemistry.

[13]  Pascale G. Charest,et al.  β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[15]  R. Lefkowitz,et al.  G protein-coupled receptor kinases. , 1998, Annual review of biochemistry.

[16]  Yang Xiang,et al.  Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. , 2004, The Journal of biological chemistry.

[17]  Olivier Lichtarge,et al.  β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor* , 2006, Journal of Biological Chemistry.

[18]  V. Jala,et al.  Phosphorylation-independent β-Arrestin Translocation and Internalization of Leukotriene B4 Receptors* , 2005, Journal of Biological Chemistry.

[19]  Mark H Ellisman,et al.  A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells , 2005, Nature Methods.

[20]  Robert J. Lefkowitz,et al.  Transduction of Receptor Signals by ß-Arrestins , 2005, Science.

[21]  J. Friedman,et al.  Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. , 2004, Molecular pharmacology.

[22]  R. Lefkowitz,et al.  Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Lefkowitz,et al.  Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling , 2003 .

[24]  Marc G. Caron,et al.  G Protein-coupled Receptor Kinase 3 (GRK3) Gene Disruption Leads to Loss of Odorant Receptor Desensitization* , 1997, The Journal of Biological Chemistry.

[25]  M. Caron,et al.  Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization , 1996, Science.

[26]  W. Koch,et al.  Therapeutic potential of G-protein coupled receptor kinases in the heart. , 1999, Expert opinion on investigational drugs.

[27]  R. Lefkowitz,et al.  Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor* , 2004, Journal of Biological Chemistry.

[28]  T. Kohout,et al.  beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Herman,et al.  Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. , 1998, Biophysical journal.

[30]  M. Caron,et al.  Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Robert J. Lefkowitz,et al.  Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Caron,et al.  Structure and regulation of G protein-coupled receptors: the beta 2-adrenergic receptor as a model. , 1991, Vitamins and hormones.

[33]  Roger Y. Tsien,et al.  A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C , 2003, The Journal of cell biology.

[34]  P. Sigler,et al.  Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. , 2001, Structure.

[35]  B. J. Knoll,et al.  Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. , 2000, Molecular pharmacology.

[36]  T. S. Kobilka,et al.  Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.

[37]  J L Benovic,et al.  Arrestin Interactions with G Protein-coupled Receptors , 1995, The Journal of Biological Chemistry.

[38]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[39]  G. Liapakis,et al.  Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor. , 2004, Molecular pharmacology.

[40]  C. Aoki,et al.  Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. , 1992, The Journal of biological chemistry.

[41]  R. Gainetdinov,et al.  Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice , 1999, Neuron.

[42]  C. Chavkin,et al.  Targeted Construction of Phosphorylation-independent β-Arrestin Mutants with Constitutive Activity in Cells* , 1999, The Journal of Biological Chemistry.